Table 1.

Clinical characteristics of all study subjects (mean ± SD)

Variable	Subjects (n= 68)
Age (years)	35.9 ± 6.7
Weight (kg)	97.0 ± 13.5
BMI (kg/m2)	36.7 ± 4.2
IGF-1 (ng/ml)	155.1 ± 59.0
25 hydroxyvitamin D (25OHD) (ng/ml)	24.1 ± 15.2
P1NP (ng/ml)	43.9 ± 18.0
Total testosterone (ng/dl)	34.3 ± 21.0
Free testosterone (ng/dl)	0.54 ± 0.43
Total estradiol (pg/ml)	115.1 ± 94.0
Free estradiol (pg/ml)	74.6 ±59.4
L4 trabecular BMD (mg/cm3)	162.4 ± 33.0
SHBG (mmol/l)	52.8 ± 37.3
CT: Abdominal TAT (cm2)	633.0 ± 145.3
CT: Abdominal SAT (cm2)	510.5 ± 121.0
CT: Abdominal VAT (cm2)	122.3 ± 50.9
CT: Thigh muscle CSA (cm2)	147.2 ± 19.0
CT: Thigh muscle density (HU)	46.8 ± 5.3
CT: Thigh SAT (cm2)	204.6 ± 57.4

P1NP: procollagen type 1 amino-terminal propeptide; SHBG: sex hormone binding globulin, BMD: bone mineral density, TAT: Total abdominal adipose tissue; SAT: Subcutaneous adipose tissue; VAT: Visceral adipose tissue, CSA: cross sectional area, HU: Hounsfield units